Literature DB >> 31015291

Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.

Robert F Hennigan1, Jonathan S Fletcher2, Steven Guard3, Nancy Ratner2.   

Abstract

Neurofibromatosis type 2 is an inherited, neoplastic disease associated with schwannomas, meningiomas, and ependymomas and that is caused by inactivation of the tumor suppressor gene NF2 The NF2 gene product, Merlin, has no intrinsic catalytic activity; its tumor suppressor function is mediated through the proteins with which it interacts. We used proximity biotinylation followed by mass spectrometry and direct binding assays to identify proteins that associated with wild-type and various mutant forms of Merlin in immortalized Schwann cells. We defined a set of 52 proteins in close proximity to wild-type Merlin. Most of the Merlin-proximal proteins were components of cell junctional signaling complexes, suggesting that additional potential interaction partners may exist in adherens junctions, tight junctions, and focal adhesions. With mutant forms of Merlin that cannot bind to phosphatidylinositol 4,5-bisphosphate (PIP2) or that constitutively adopt a closed conformation, we confirmed a critical role for PIP2 binding in Merlin function and identified a large cohort of proteins that specifically interacted with Merlin in the closed conformation. Among these proteins, we identified a previously unreported Merlin-binding protein, apoptosis-stimulated p53 protein 2 (ASPP2, also called Tp53bp2), that bound to closed-conformation Merlin predominately through the FERM domain. Our results demonstrate that Merlin is a component of cell junctional mechanosensing complexes and defines a specific set of proteins through which it acts.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31015291      PMCID: PMC6631321          DOI: 10.1126/scisignal.aau8749

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  113 in total

1.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

Review 2.  Converging and Unique Mechanisms of Mechanotransduction at Adhesion Sites.

Authors:  Mitchell K L Han; Johan de Rooij
Journal:  Trends Cell Biol       Date:  2016-03-29       Impact factor: 20.808

3.  Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.

Authors:  Taru Muranen; Mikaela Grönholm; G Herma Renkema; Olli Carpén
Journal:  Oncogene       Date:  2005-02-10       Impact factor: 9.867

4.  ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.

Authors:  Virginie Vives; Jian Su; Shan Zhong; Indrika Ratnayaka; Elizabeth Slee; Robert Goldin; Xin Lu
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

5.  The merlin tumor suppressor localizes preferentially in membrane ruffles.

Authors:  C Gonzalez-Agosti; L Xu; D Pinney; R Beauchamp; W Hobbs; J Gusella; V Ramesh
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

6.  A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism.

Authors:  Hadar Benyamini; Hadas Leonov; Shahar Rotem; Chen Katz; Isaiah T Arkin; Assaf Friedler
Journal:  Proteins       Date:  2009-11-15

7.  Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.

Authors:  D Lallemand; J Manent; A Couvelard; A Watilliaux; M Siena; F Chareyre; A Lampin; M Niwa-Kawakita; M Kalamarides; M Giovannini
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

8.  The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.

Authors:  R F Hennigan; C A Moon; L M Parysek; K R Monk; G Morfini; S Berth; S Brady; N Ratner
Journal:  Oncogene       Date:  2012-04-23       Impact factor: 9.867

9.  Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.

Authors:  Krishna Chinthalapudi; Vinay Mandati; Jie Zheng; Andrew J Sharff; Gerard Bricogne; Patrick R Griffin; Joseph Kissil; Tina Izard
Journal:  Nat Commun       Date:  2018-04-06       Impact factor: 14.919

10.  Mechanosensing and Regulation of Cardiac Function.

Authors:  David E Dostal; Hao Feng; Damir Nizamutdinov; Honey B Golden; Syeda H Afroze; Joseph D Dostal; John C Jacob; Donald M Foster; Carl Tong; Shannon Glaser; Fnu Gerilechaogetu
Journal:  J Clin Exp Cardiolog       Date:  2014-06-05
View more
  3 in total

Review 1.  Proximity Dependent Biotinylation: Key Enzymes and Adaptation to Proteomics Approaches.

Authors:  Payman Samavarchi-Tehrani; Reuben Samson; Anne-Claude Gingras
Journal:  Mol Cell Proteomics       Date:  2020-03-03       Impact factor: 5.911

Review 2.  Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.

Authors:  Chin-Lin Guo
Journal:  Front Cell Dev Biol       Date:  2022-06-14

3.  JAM-A signals through the Hippo pathway to regulate intestinal epithelial proliferation.

Authors:  Shuling Fan; Michelle Sydney Smith; Justin Keeney; Monique N O'Leary; Asma Nusrat; Charles A Parkos
Journal:  iScience       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.